- Home
- IMRX vs NTRB Comparison
IMRX vs NTRB Comparison
Compare IMRX & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- NTRB
- Stock Information
- Founded
- IMRX 2008
- NTRB 2016
- Country
- IMRX United States
- NTRB United States
- Employees
- IMRX N/A
- NTRB N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- IMRX Health Care
- NTRB Health Care
- Exchange
- IMRX Nasdaq
- NTRB Nasdaq
- Market Cap
- IMRX 62.7M
- NTRB 74.7M
- IPO Year
- IMRX 2021
- NTRB N/A
- Fundamental
- Price
- IMRX $1.64
- NTRB $6.26
- Analyst Decision
- IMRX Strong Buy
- NTRB Buy
- Analyst Count
- IMRX 3
- NTRB 1
- Target Price
- IMRX $11.00
- NTRB $13.00
- AVG Volume (30 Days)
- IMRX 192.2K
- NTRB 22.2K
- Earning Date
- IMRX 03-20-2025
- NTRB 04-30-2025
- Dividend Yield
- IMRX N/A
- NTRB N/A
- EPS Growth
- IMRX N/A
- NTRB N/A
- EPS
- IMRX N/A
- NTRB N/A
- Revenue
- IMRX N/A
- NTRB $2,021,771.00
- Revenue This Year
- IMRX N/A
- NTRB $7.95
- Revenue Next Year
- IMRX N/A
- NTRB $538.25
- P/E Ratio
- IMRX N/A
- NTRB N/A
- Revenue Growth
- IMRX N/A
- NTRB N/A
- 52 Week Low
- IMRX $1.00
- NTRB $3.20
- 52 Week High
- IMRX $3.83
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- IMRX 46.94
- NTRB 42.80
- Support Level
- IMRX $1.60
- NTRB $6.37
- Resistance Level
- IMRX $1.91
- NTRB $6.85
- Average True Range (ATR)
- IMRX 0.11
- NTRB 0.32
- MACD
- IMRX 0.02
- NTRB -0.01
- Stochastic Oscillator
- IMRX 44.90
- NTRB 28.89
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.